The golden hour of prehospital reperfusion with triple antiplatelet therapy: A sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy

American Heart Journal

Volumn 160, Issue 6, 2010, Pages 1079-1084

  Heestermans, Ton ^a   Van 'T Hof, Arnoud W J ^b   Ten Berg, Jurriën M ^c   Van Werkum, Jochem W ^c   Boersma, Eric ^d   Mosterd, Arend ^e,f   Stella, Pieter R ^f   Van Zoelen, Arthur B ^c   Gosselink, A T Marcel ^b   Kochman, Waclav ^g   Dill, Thorsten ^h   Koopmans, Petra C ⁱ   Van Houwelingen, Gert ^j   Zijlstra, Felix ^k   Hamm, Christian ^h  

^a Northwest Clinics   (Netherlands)

^b Isala Klinieken ^*  (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e MEANDER MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g Department of Cardiology   (Poland)

^h KERCKHOFF HEART CENTER   (Germany)

ⁱ Diagram BV   (Netherlands)

^j MEDISCH SPECTRUM TWENTE   (Netherlands)

^k UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE; HEPARIN; LYSINE ACETYLSALICYLATE; PLACEBO; TIROFIBAN;

ABORTED MYOCARDIAL INFARCTION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; DRUG MEGADOSE; EARLY INTERVENTION; EMERGENCY CARE; FEMALE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ST SEGMENT RESOLUTION; TRIPLE ANTICOAGULANT THERAPY; VASCULAR PATENCY;

ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EMERGENCY MEDICAL SERVICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; TIME FACTORS; TREATMENT OUTCOME; TYROSINE; YOUNG ADULT;

EID: 78650079871     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.08.039     Document Type: Article

References (20)

1. Canadian Cardiovascular Society; American Academy of Family Physicians; American College of Cardiology; American Heart Association Antman E.M., Hand M., and Armstrong P.W. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
2. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial Lancet 367 2006 569 578
3. Zijlstra F., Ernst N., and de Boer M.J. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction J Am Coll Cardiol 39 2002 1733 1737
4. Vlaar P.J., Svilaas T., and Damman K. Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review Circulation 118 2008 1828 1836
5. Ellis S.G., Tendera M., and de Belder M.A. Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217
6. Montalescot G., Borentain M., and Payot L. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis JAMA 292 2004 362 366
7. De Luca G., Gibson C.M., and Bellandi F. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis Heart 94 2008 1548 1558
8. Boersma E., Maas A.C., and Deckers J.W. Early thrombolytic therapy in acute myocardial infarction: reappraisal of the golden hour Lancet 348 1996 771 775
9. Heestermans A.A., van Werkum J.W., and Hamm C. Marked reduction of early stent thrombosis with pre-hospital initiation of high dose tirofiban in ST-segment elevation myocardial infarction: an analysis of the ON-TIME 2 trial J Thromb Haemost 7 2009 1612 1618
10. van 't Hof A.W.J., ten Berg J., and Heestermans T. Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Lancet 372 2008 537 546
11. Schröder R., Dissmann R., and Brüggemann T. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction J Am Coll Cardiol 24 1994 384 391
12. van 't Hof A.W.J., Liem A., and de Boer M.J. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group Lancet 350 1997 615 619
13. The TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings N Engl J Med 312 1985 932 936
14. ten Berg J.M., van 't Hof A.W.J., and Dill T. On-TIME 2 Study Group. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome J Am Coll Cardiol 55 2010 2446 2455
15. Aquilina M., Varani E., and Balducelli M. Administration of eptifibatide during transfer for primary PCI in patients with STEMI: effect on Pre-PCI TIMI flow and its correlation with pain-to-therapy time J Invasive Cardiol 21 2009 115 120
16. Boersma E., Harrington R.A., and Moliterno D.J. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials Lancet 359 2002 189 198
17. Anderson J.L., Karagounis L.A., and Califf R.M. Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction Am J Cardiol 78 1996 1 8
18. Verheugt F.W., Gersh B.J., and Armstrong P.W. Aborted myocardial infarction: a new target for reperfusion therapy Eur Heart J 27 2006 901 904
19. Cantor W.J., Fitchett D., and Borgundvaag B. Routine early angioplasty after fibrinolysis for acute myocardial infarction N Engl J Med 360 2009 2705 2718
20. Mehilli J., Kastrati A., and Schulz S. Bavarian Reperfusion Alternatives Evaluation-3 (BRAVE-3) Study Investigators. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial Circulation 119 2009 1933 1940